Biogen (NASDAQ:BIIB) Q3 2026 Earnings Call
Biogen (NASDAQ:BIIB) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Biogen Inc. (NASDAQ:BIIB)
- Period
- Q3 2026 earnings call
- Date
- Wed, Oct 28, 2026, 8:30 AM ET
Latest news releases
- NASDAQ:BIIB — Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for… · Fri, Oct 2, 2026
- NASDAQ:BIIB — Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or… · Thu, Sep 17, 2026